Eduardo A. Guzman

Eduardo A. Guzman MD. Surgical Oncology.

[Mark Lewis, MD, FASCO @marklewismd]

Cheers, chills, and a standing ovation when RASolute 302 showed unprecedented survival on daraxonrasib for patients with progressive pancreatic cancer

Seldom do you sense you’re witnessing a historic moment in cancer care but this feels like ras targeting has arrived

#ASCO26

[Escuela de Medicina y Ciencias de la Salud @emcs_tecdemty]

La EMCS del @TecdeMonterrey afirma su liderazgo académico con resultados sobresalientes en el #ENARM.

Nuestras sedes continúan posicionándose sostenidamente entre los primeros lugares de la CDMX y del país en aceptación y conocimientos médicos.

[Eduardo A. Guzman @eduguzman]

I commend this effort by the american college of surgeons in making surgery safer. A surgical intervention is a high stakes situation that requires the surgeon to be in optimal physical and mental state. Acting like fatigue doesn´t matter puts patients at risk for bad outcomes.

[Eduardo A. Guzman @eduguzman]

I commend this effort by the american college of surgeons in making surgery safer. A surgical intervention is a high stakes situation that requires the surgeon to be in optimal physical and mental state. Acting like fatigue doesn´t matter puts patients at risk for bad outcomes.

[Annals of Surgery @AnnalsofSurgery]

In an international multicenter study, minimally invasive and open pancreatoduodenectomy demonstrated comparable oncologic and survival outcomes for both intestinal and pancreatobiliary ampullary adenocarcinoma subtypes. https://t.co/zi4VprA2P8

[JAMA Surgery @JAMASurgery]

In the STITCH trial, small-bites fascial closure for elective midline laparotomy was associated w/ reduced long-term incidence and size of incisional hernias vs large-bites closure. At 13 years, cumulative incidence and width of hernias >20 mm were lower w/ small-bites technique.

[Dr. Marty Makary @DrMakaryFDA]

Great to be among fellow surgeons at @AANSNeuro.

FDA is working hard to accelerate game-changing treatments and put the best tools possible in the hands of neurosurgeons.

[Eduardo A. Guzman @eduguzman]

Una nueva alternativa de tratamiento para pacientes con cancer de pancreas metastasico. Pendientes de la sesión plenaria en ASCO 2026

[Dr. Marty Makary @DrMakaryFDA]

TWO DAYS after receiving the application, FDA greenlit the new pancreatic cancer drug daraxonrasib for expanded access.

This drug has also been granted a national priority voucher, which means a full application could be reviewed in a matter of weeks instead of 10-12 months.

[Eduardo A. Guzman @eduguzman]

It turns out that a gastric drainage procedure is helpful after all (at least in the short term. Would like to see a comparison with botulinum toxin pyloric injection.

[Annals of Surgery @AnnalsofSurgery]

A phase III randomized trial of pyloroplasty during minimally invasive esophagectomy was stopped early after demonstrating fewer short-term complications than no pyloroplasty. https://t.co/Eu1Py2hgnP

[Annals of Surgery @AnnalsofSurgery]

A phase III randomized trial of pyloroplasty during minimally invasive esophagectomy was stopped early after demonstrating fewer short-term complications than no pyloroplasty. https://t.co/Eu1Py2hgnP

[Eduardo A. Guzman @eduguzman]

@PatricioPolanc0 Congratulations !

[Eduardo A. Guzman @eduguzman]

@PatricioPolanc0 @ProfDemartines @JBMrobotics Awesome !

[Eduardo A. Guzman @eduguzman]

@FlavioRochaMD @SSATNews @OHSUKnight @SAGES_Updates I am still placing jejunostomy tubes after whipples for this very reason. I believe in optimal enteral nutrition as a cornerstone of postoperative management.

[Eduardo A. Guzman @eduguzman]

Proud member of the Society of Surgical Oncology!

[Eduardo A. Guzman @eduguzman]

New EsMO guideline update. Metastatic colorectal cancer https://t.co/PtLTabuw2y

[Eduardo A. Guzman @eduguzman]

Surgeon life!

[Eduardo A. Guzman @eduguzman]

TIEMPO FUERA (VP CCx26) https://t.co/X4DLlns5TF vía @YouTube

[Eduardo A. Guzman @eduguzman]

Best part of SSO